Adding complexity to the puzzle, comparing the effect of p53 on response to TMZ in traditional glioma cell lines and brain tumor initiating cells (BTICs), opposite outcomes have been observed: while traditional cell lines with altered p53 expression were significantly more sensitive to TMZ, BTICs with altered p53wt expression/function were more resistant to the drug [194]. This evidence concerns the gene TP53 and brain neoplasm.